USD 3.95
(1.8%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 236.49 Thousand USD | -68.42% |
2022 | 748.93 Thousand USD | 128.37% |
2021 | -2.64 Million USD | -174.1% |
2020 | 3.56 Million USD | 41.5% |
2019 | 2.51 Million USD | 170.01% |
2018 | 932.51 Thousand USD | -58.13% |
2017 | 2.22 Million USD | 104.22% |
2016 | 1.09 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 1.17 Million USD | 398.75% |
2024 Q2 | 80.81 Million USD | 6751.63% |
2023 Q3 | -735.89 Thousand USD | 58.29% |
2023 FY | 236.49 Thousand USD | -68.42% |
2023 Q1 | -2.13 Million USD | -385.08% |
2023 Q4 | 236.49 Thousand USD | 132.14% |
2023 Q2 | -1.76 Million USD | 17.36% |
2022 Q2 | -4.91 Million USD | 16.96% |
2022 FY | 748.93 Thousand USD | 128.37% |
2022 Q4 | 748.93 Thousand USD | 149.81% |
2022 Q3 | -1.5 Million USD | 69.43% |
2022 Q1 | -5.92 Million USD | -124.36% |
2021 Q3 | -9.66 Million USD | 0.0% |
2021 FY | -2.64 Million USD | -174.1% |
2021 Q4 | -2.64 Million USD | 72.67% |
2020 FY | 3.56 Million USD | 41.5% |
2019 FY | 2.51 Million USD | 170.01% |
2018 FY | 932.51 Thousand USD | -58.13% |
2017 FY | 2.22 Million USD | 104.22% |
2016 FY | 1.09 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
American Bio Medica Corporation | 2.2 Million USD | 89.279% |
Arrayit Corporation | 1.05 Million USD | 77.596% |
Biocept, Inc. | -788 Thousand USD | 130.012% |
Bioqual, Inc. | -12 Million USD | 101.97% |
CardioGenics Holdings Inc | 22.73 Thousand USD | -940.046% |
DermTech, Inc. | 17.65 Million USD | 98.66% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 100.041% |
HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 103.206% |
iMD Companies, Inc. | 1.11 Million USD | 78.807% |
IDenta Corp. | 524.85 Thousand USD | 54.94% |
Interpace Biosciences, Inc. | 7.69 Million USD | 96.926% |
Integrative Health Technologies, Inc. | -26.95 Thousand USD | 977.471% |
InVitro International | -313.14 Thousand USD | 175.524% |
Lumos Diagnostics Holdings Limited | 1.56 Million USD | 84.897% |
Many Bright Ideas Technologies Inc. | -713.00 USD | 33269.144% |
Medical Imaging Corp. | 3.79 Million USD | 93.762% |
NovelStem International Corp. | 3.52 Million USD | 93.284% |
Optigenex Inc. | 8.93 Million USD | 97.353% |
PharmChem, Inc. | -1.49 Million USD | 115.825% |
Proteome Sciences plc | 14.57 Million USD | 98.377% |
Response Genetics, Inc | -13.08 Million USD | 101.807% |
Rennova Health, Inc. | 14.82 Million USD | 98.405% |
RushNet, Inc. | 4.8 Million USD | 95.074% |
ScreenPro Security Inc. | 135.58 Thousand USD | -74.421% |
Stella Diagnostics Inc. | 6.19 Million USD | 96.181% |
StageZero Life Sciences Ltd. | 1.78 Million USD | 86.746% |
Todos Medical Ltd. | 38.31 Million USD | 99.383% |